Bioren
About Bioren
Antibody discovery and optimization company developing a rational approach to antibody engineering.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: M&A
- Last round: Seed (Dec 2002)
- Phone: (650)654-5811
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/bioren-649427 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.